RE:Optimized Maintenance Study Treatment I was under the impression that 4 of the 1st set of 12 were due to get a second treatment which was to be an Optimized Procedure, plus all patients from 13 and on. It will all be clear when we have enough patients who have received at least one or 2 optimized treatments and see the CR rate for this group. So far 2 on 2 from PH1 and 2 on 3 from PH2 for patients 13,14 & 15( would probably have been 3 on 3 as patient who sadly passed away was showing negative Urine Cytology at 30 days) . So added together that's 4 on 5 ( would have probably been 5 on 5 IMo). We need to see how many are CR post 2nd optimized treatment given at 180 days. The 9 months data (270 days) 3 months later for these patients as well as 3 and 6 months data next Q for patients 13-18. That may be the tipping point where it will be obvious that an Optimized Treatment could hopefully yield unparalleled results. Just IMO
Eoganacht wrote: Theralase has confirmed that 2 patients have recieved the optimized maintenance study treatment in study 2.
This number was inadvertently left blank on page 6 of the MD&A.